Cox regression analysis demonstrated that SPTBN2 is significantly correlated with PFI in STES, PAAD, STAD, uveal melanoma (UVM), prostate adenocarcinoma (PRAD), KIRC, and BLCA (Fig. 2c, p < 0.05). Here, SPTBN2 is linked to bladder transitional cell carcinoma.